Evidence map›Paper›PMID 30310509›Full record

ArticleJournal of Cancer2018

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.

Lei Zhang, Yi Wang, Zhiqiang Qin, Ran Li, Rong Cong, Chengjian Ji, Xianghu Meng, Yamin Wang, Jiadong Xia, Ninghong Song

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lei ZhangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Yi WangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Zhiqiang QinDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Ran LiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Rong CongDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Chengjian JiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Xianghu MengDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Yamin WangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Jiadong XiaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Ninghong SongDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bladder cancerMeta-analysisPolymorphismTP53 codon 72

Identifiers

PMID30310509
PMCPMC6171014
OpenAlexW2889847066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.